Abstract
BackgroundHHIs, vismodegib and sonidegib, are approved for treatment of patients with mBCC or locally advanced BCC who are not candidates for surgery or radiation. There is no approved option for...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have